15.12.2016

Novo A/S becomes a strategic investor in SYNLAB

Munich / Hellerup, 15 December 2016 – SYNLAB Limited (“SYNLAB” or “the Group”) and Novo A/S (“Novo”), the holding company for the Novo Group, today jointly announce that Novo has exercised its option to acquire a stake in the … 

Category: Corporate News, Corporation
18.11.2016

SYNLAB successfully raised almost EUR 1 billion and will pursue its strategic acquisitions

SYNLAB (also the "Group"), the leading provider of laboratory services in Europe, announced earlier this week the closing of the offering of Senior Secured Floating Rate Notes (the “Notes”). Taking advantage of the favourable … 

Category: Corporate News, Corporation
08.06.2016

Dr Christoph Mahnke appointed new CEO and managing director of SYNLAB Holding

Augsburg, 08.06.2016 – Dr Christoph Mahnke will assume the position of CEO and managing director of SYNLAB Holding Deutschland GmbH effective 1 October 2016. SYNLAB Holding Deutschland is the German subsidiary of Europe’s largest … 

Category: Corporate News, Corporation
18.05.2016

Synlab successfully prices an offering of €190m of additional senior secured floating rate notes due 2022

Synlab Limited ("Synlab" or the "Group"), the largest European clinical laboratories company, today announces that its subsidiary, Synlab Bondco PLC, has successfully priced a private placement offering (the "Offering") of €190 … 

Category: Corporate News, Corporation
30.03.2016

Philippe Charrier, Non-Executive Chairman of Synlab Group to step down

Synlab Limited (‘Synlab’ or ‘the Group’), the largest European clinical laboratories company, today announces that Philippe Charrier, currently non-executive Chairman, will be leaving the Group on 1 April 2016 after more than … 

Category: Corporate News, Corporation
03.02.2016

Novo A/S expands its large investment portfolio through investment in Synlab and enters the European central laboratory services industry

Synlab Limited (‘Synlab’ or ‘the Group’), the largest European clinical laboratories company, and Novo A/S (‘Novo’), the holding company for the Novo Group and fully owned subsidiary of the Novo Nordisk Foundation, today announce … 

Category: Corporate News, Corporation
01.10.2015

Cinven completes acquisition of synlab

Cinven has today completed the acquisition of synlab, one of the largest European operators of medical diagnostic laboratories, headquartered in Germany. 

Category: Corporation, Corporate News
13.07.2015

Labco and synlab - Senior Appointments

The European clinical diagnostics businesses, Labco and synlab, today announce that Dr. Bartl Wimmer will be appointedas Group Chief Executive and Philippe Charrier as Executive Chairman of the combined group. 

Category: Corporate News, Corporation
26.06.2015

Cinven will acquire a majority stake in the synlab Group

in cooperation with Labco for further growth in Europe 

Category: Corporate News, Corporation
28.05.2015

Labco announces investment by European private equity firm Cinven in the company

Cinven cites strength of business and growth drivers in the Medical Diagnostic Market as key reasons for investment 

Category: Corporate News, Corporation